Home/Filings/4/0000899243-17-024006
4//SEC Filing

STARR KEVIN P 4

Accession 0000899243-17-024006

CIK 0001649904other

Filed

Oct 10, 8:00 PM ET

Accepted

Oct 11, 4:00 PM ET

Size

18.3 KB

Accession

0000899243-17-024006

Insider Transaction Report

Form 4
Period: 2017-10-10
Transactions
  • Conversion

    Common Stock

    2017-10-10+3,963,8103,981,437 total
  • Conversion

    Series A Convertible Preferred Stock

    2017-10-109,479,5020 total
    Common Stock (1,033,751 underlying)
  • Conversion

    Series A-1 Junior Preferred Stock

    2017-10-1026,868,6420 total
    Common Stock (2,930,059 underlying)
TRV GP, LLC
10% Owner
Transactions
  • Conversion

    Common Stock

    2017-10-10+3,963,8103,981,437 total
  • Conversion

    Series A Convertible Preferred Stock

    2017-10-109,479,5020 total
    Common Stock (1,033,751 underlying)
  • Conversion

    Series A-1 Junior Preferred Stock

    2017-10-1026,868,6420 total
    Common Stock (2,930,059 underlying)
STARR KEVIN P
10% Owner
Transactions
  • Conversion

    Series A Convertible Preferred Stock

    2017-10-109,479,5020 total
    Common Stock (1,033,751 underlying)
  • Conversion

    Series A-1 Junior Preferred Stock

    2017-10-1026,868,6420 total
    Common Stock (2,930,059 underlying)
  • Conversion

    Common Stock

    2017-10-10+3,963,8103,981,437 total
Transactions
  • Conversion

    Series A-1 Junior Preferred Stock

    2017-10-1026,868,6420 total
    Common Stock (2,930,059 underlying)
  • Conversion

    Common Stock

    2017-10-10+3,963,8103,981,437 total
  • Conversion

    Series A Convertible Preferred Stock

    2017-10-109,479,5020 total
    Common Stock (1,033,751 underlying)
Transactions
  • Conversion

    Common Stock

    2017-10-10+3,963,8103,981,437 total
  • Conversion

    Series A-1 Junior Preferred Stock

    2017-10-1026,868,6420 total
    Common Stock (2,930,059 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    2017-10-109,479,5020 total
    Common Stock (1,033,751 underlying)
LEVIN MARK J
10% Owner
Transactions
  • Conversion

    Common Stock

    2017-10-10+3,963,8103,981,437 total
  • Conversion

    Series A Convertible Preferred Stock

    2017-10-109,479,5020 total
    Common Stock (1,033,751 underlying)
  • Conversion

    Series A-1 Junior Preferred Stock

    2017-10-1026,868,6420 total
    Common Stock (2,930,059 underlying)
Footnotes (3)
  • [F1]Represents the total number of shares of Common Stock received by Third Rock Ventures, L.P. ("TRV") upon conversion of the Series A Convertible Preferred Stock and Series A-1 Junior Preferred Stock of the Issuer in connection with the closing of the Issuer's initial public offering.
  • [F2]The Series A Convertible Preferred Stock and Series A-1 Junior Preferred Stock converted into Common Stock on a 9.17-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Convertible Preferred Stock and Series A-1 Junior Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date.
  • [F3]These shares are directly held by TRV. The general partner of TRV is Third Rock Ventures GP, L.P. ("TRV GP"). The general partner of TRV GP is TRV GP, LLC ("TRV GP LLC"). The individual managers of TRV GP LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.

Issuer

RHYTHM PHARMACEUTICALS, INC.

CIK 0001649904

Entity typeother

Related Parties

1
  • filerCIK 0001192603

Filing Metadata

Form type
4
Filed
Oct 10, 8:00 PM ET
Accepted
Oct 11, 4:00 PM ET
Size
18.3 KB